About
2.43USD-0.05 -2.02%
Closed • Updated at 22:09 GMT+00:00Market Cap$74.09M
Volume15.2K
Beta1.10
RSI46.44
Xbiotech Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Jun 18 2024
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Jan 4 2024
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
Sep 26 2023
XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
Aug 30 2023
XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer
Aug 8 2023
XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial
Community Chat
Ask AI
Try asking
Google Übersetzer